Cytophenix is transforming infection management with rapid antimicrobial susceptibility tests, providing swift, accurate results to identify effective antibiotics for each patient.
Cytophenix
Follow
Get notifications in MyBN when activity occurs.
Company Activity
|
NEWS: Tagged in Health and vitality of Perkins biomedical sector is ripe for investment | 15 Dec 2025 |
|
NEWS: Tagged in Cytophenix completes pre-seed round | 13 Nov 2025 |
|
NEW ROLE: Kieran Mulroney, CEO | 13 Nov 2025 |
Sponsored Content
News Articles
Related Information
Notable People
| Name | Position | Year Started |
|---|---|---|
CEO
|
2024 |
